Condition
Oligodendroglioma, Adult
Total Trials
4
Recruiting
0
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Not Yet Recruiting1
Active Not Recruiting1
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05393258Not ApplicableCompleted
Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas
NCT03969706Phase 2Active Not RecruitingPrimary
Abemaciclib in Patients with Oligodendroglioma
NCT05536986Not Yet RecruitingPrimary
Correlation Between Psychological Stress and Progression of Newly Oligodendroglioma Towards Secondary Glioma
NCT00003472Phase 2TerminatedPrimary
Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma
Showing all 4 trials